Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

OPTIMAL Pain & Regenerative Medicine Brings Cutting Edge Platelet Rich Plasma (PRP) and Bone Marrow Aspirate Concentrate (BMAC) Therapies to Dallas-Forth Worth
  • USA - English
  • USA - English


News provided by

OPTIMAL Pain & Regenerative Medicine

Feb 25, 2015, 04:00 ET

Share this article

Share toX

Share this article

Share toX

PRP and BMAC use the body’s natural healing abilities to accelerate the treatment of back pain, joint, tendon and ligament injuries.
PRP and BMAC use the body’s natural healing abilities to accelerate the treatment of back pain, joint, tendon and ligament injuries.

Regenerative medicine offers new hope to patients suffering from back pain and sports related injuries.

Post this

Forth Worth, Texas (PRWEB) February 25, 2015 -- Board Certified Anesthesiology and Pain Medicine physicians, Scott Berlin, M.D., Andrew Cottingham, M.D., and Michael Scott Phillips, M.D. have created a new division of Pinnacle Pain Medicine offering state of the art biologic therapies to the Dallas-Ft. Worth Metropex. The new division, called OPTIMAL Pain & Regenerative Medicine, will provide pain management and regenerative therapies at offices in Alliance, Arlington, Burleson, Cleburne and Ft. Worth. These therapies, - Platelet Rich Plasma (PRP) and Bone Marrow Aspirate Concentrate (BMAC) - are used to treat neck and back pain, arthritis, joint and soft-tissue injuries and sports related injuries.

It is estimated that 116 million American adults will suffer from some degree of chronic pain during their lives. Since pain is debilitating both physically and emotionally, it is important to manage it the right way. Traditionally, patients seeking relief from pain are treated with injection/interventional therapy, implantable therapies, medication management and physical therapy.

For patients whose pain cannot be successfully managed with these treatments and therapies, Regenerative Medicine may offer new hope. OPTIMAL currently offers two forms of regenerative treatments, platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC). PRP and BMAC are both non-surgical treatment options that use the body’s natural healing abilities to accelerate the treatment of back pain, joint, tendon and ligament injuries.

Platelet-Rich Plasma, commonly known as PRP, is an advanced regenerative therapy that uses the patient’s own blood components to help rebuild damaged tissue. First, blood is drawn and separated by a centrifuge device to create a concentrate of platelets in plasma. This platelet concentrate contains multiple growth factors that are essential in inducing and accelerating tissue repair and regeneration. Using the most advanced tissue guidance with ultrasound, the PRP concentrate is then injected into the damaged areas including connective tissues, bone, and hyaline cartilages to expedite the development of new blood vessels necessary for tissue healing.

A more advanced form of regenerative therapy is bone marrow aspirate concentrate, BMAC. Through a simple outpatient procedure, BMAC involves the removal of the patient’s own bone marrow from the pelvic bones (Iliac crest). This bone marrow is concentrated to contain all of the growth and healing factors that are contained in PRP, along with concentrated “pluripotent” (stem-like) nucleated cells that further contribute to the regenerative process. BMAC is used to help regenerate joint cartilage and spinal discs and may significantly speed the healing process for other injuries. It is often used in cases with significant tissue damage, or when other types of regenerative therapies have failed.

Regenerative medicine is on the forefront of innovative treatment. To date, many professional athletes, amateur and collegiate athletes around that world have been successfully treated with PRP and BMAC. If you are interested in exploring the treatment options for regenerative medicine, please contact us at 817-472-2140 or visit our website at OptimalDFW.com.

About Our Doctors

Drs. Scott Berlin, Andrew Cottingham and Michael Phillips are all double board certified in anesthesiology and pain medicine. Dr. Berlin was the first practitioner in Dallas to implant a fully implantable dual lead spinal cord stimulator system, which has now become the standard of care. Dr. Cottingham has been working exclusively in pain medicine since 2003, by providing comprehensive interventional pain therapies to patient in North Texas. Dr. Phillips began practicing both anesthesiology and pain medicine in 1999 and began practicing pain medicine exclusively in 2007. Dr. Phillips was the first physician in the Dallas-Fort Worth area to perform the intradiscal BMAC procedure.

Shannon Moyers, OPTIMAL Pain & Regenerative Medicine, http://dfwregenerativemedicine.com/, +1 (214) 293-6581, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.